Your Article Summary
See Latest ArticlesTalent Stent Graft Shows Durable Performance in Patients with Abdominal Aortic Aneurysms
Medtronic, 06/16/09
Through five years following initial implantation in an FDA-approved study, the Talent Abdominal Stent Graft from Medtronic, Inc. , demonstrated durable safety and effectiveness in patients with abdominal aortic aneurysms, despite having included patients with more challenging anatomies than comparable trials of similar medical devices.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09